MF buys: IndusInd Bank, BoI, Divi’s Labs, GSK Pharma and Aditya Birla Capital among top MF buys

MF buys: IndusInd Bank, BoI, Divi’s Labs, GSK Pharma and Aditya Birla Capital among top MF buys

Mutual fund managers are increasingly being choosy while picking stocks in the mid-cap and smallcap space amid concerns over rich valuations. In January, they selectively bought pharmaceuticals, while shuffling their holdings in the banking and financial services industry (BFSI) space after shares of private lenders fell on worries about their profitability. Some of their top … Read more

GSK Pharma net profit down in Q3 – Latest News | India Business News

GSK Pharma net profit down in Q3 – Latest News | India Business News

GSK Pharma reported a decline in net profit by 72% to Rs 46 crore for the third quarter ended December 31, in the wake of regulatory price caps on some of its legacy brands. The drug firm had reported a net profit of Rs 165 crore in the year-ago period. The company’s total income increased … Read more